Senti Biosciences Holdings, Inc. (SNTI)
0.3868
0.00 (0.00%)
USD |
NASDAQ |
Aug 26, 16:00
0.3868
0.00 (0.00%)
After-Hours: 18:11
Senti Biosciences Holdings Total Assets (Quarterly) : 33.10M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 33.10M |
| March 31, 2026 | 38.24M |
| December 31, 2025 | 51.22M |
| September 30, 2025 | 52.68M |
| June 30, 2025 | 68.54M |
| March 31, 2025 | 82.78M |
| December 31, 2024 | 97.84M |
| September 30, 2024 | 57.72M |
| June 30, 2024 | 86.91M |
| March 31, 2024 | 102.18M |
| December 31, 2023 | 119.48M |
| Date | Value |
|---|---|
| September 30, 2023 | 131.77M |
| June 30, 2023 | 143.63M |
| March 31, 2023 | 161.42M |
| December 31, 2022 | 180.79M |
| September 30, 2022 | 189.44M |
| June 30, 2022 | 202.36M |
| March 31, 2022 | 230.92M |
| December 31, 2021 | 96.70M |
| September 30, 2021 | 231.66M |
| June 30, 2021 | 231.89M |
| March 31, 2021 | 0.3737M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| NovelStem International Corp. | 0.0647M |
| Brainstorm Cell Therapeutics, Inc. | 0.788M |
| Summit Therapeutics, Inc. | 752.18M |
| Kezar Life Sciences, Inc. | 68.00M |
| Protara Therapeutics, Inc. | 176.09M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 36.51M |
| Shareholders Equity (Quarterly) | -3.401M |
| Debt to Equity Ratio | -5.947 |
| Current Ratio | 0.8251 |
| Net Debt Paydown Yield | 7.13% |